Prolactin and estradiol utilize distinct mechanisms to increase serine-118 phosphorylation and decrease levels of estrogen receptor a in T47D breast cancer cells

Yen-Hao Chen, Kuangtzu Huang, Kuanhui E. Chen, Ameae M. Walker

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Potential interactions between prolactin (PRL) and estradiol (E2) in breast cancer cells were explored by examining the effect of PRL on estrogen receptor (ER) serine-118 phosphorylation, ER down-regulation, and E2-stimulated cell proliferation. Both E2 and PRL resulted in prolonged ERα serine-118 phosphorylation, but used different signaling pathways to achieve this end. Both hormones also decreased the amount of ERα, but the mechanisms were different: for E2, the decrease was rapid and resulted from proteasomic degradation, whereas for PRL the decrease was slow and resulted from an effect on levels of ERα mRNA. PRL alone had no effect on cell number, but enhanced the increase in number in response to E2. These results are the first to demonstrate similar effects of PRL and E2 on parameters considered key to E2's effects. This suggests heretofore unrecognized and potentially important interactions between these two hormones in the natural history of breast cancer.

Original languageEnglish (US)
Pages (from-to)369-377
Number of pages9
JournalBreast Cancer Research and Treatment
Volume120
Issue number2
DOIs
StatePublished - Apr 1 2010

Fingerprint

Estrogen Receptors
Prolactin
Serine
Estradiol
Phosphorylation
Breast Neoplasms
Hormones
Down-Regulation
Cell Count
Cell Proliferation
Messenger RNA

Keywords

  • Breast cancer
  • Crosstalk
  • Estrogen receptor
  • Prolactin

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Prolactin and estradiol utilize distinct mechanisms to increase serine-118 phosphorylation and decrease levels of estrogen receptor a in T47D breast cancer cells. / Chen, Yen-Hao; Huang, Kuangtzu; Chen, Kuanhui E.; Walker, Ameae M.

In: Breast Cancer Research and Treatment, Vol. 120, No. 2, 01.04.2010, p. 369-377.

Research output: Contribution to journalArticle

@article{49b4132342004b3e9fbcc050879f029b,
title = "Prolactin and estradiol utilize distinct mechanisms to increase serine-118 phosphorylation and decrease levels of estrogen receptor a in T47D breast cancer cells",
abstract = "Potential interactions between prolactin (PRL) and estradiol (E2) in breast cancer cells were explored by examining the effect of PRL on estrogen receptor (ER) serine-118 phosphorylation, ER down-regulation, and E2-stimulated cell proliferation. Both E2 and PRL resulted in prolonged ERα serine-118 phosphorylation, but used different signaling pathways to achieve this end. Both hormones also decreased the amount of ERα, but the mechanisms were different: for E2, the decrease was rapid and resulted from proteasomic degradation, whereas for PRL the decrease was slow and resulted from an effect on levels of ERα mRNA. PRL alone had no effect on cell number, but enhanced the increase in number in response to E2. These results are the first to demonstrate similar effects of PRL and E2 on parameters considered key to E2's effects. This suggests heretofore unrecognized and potentially important interactions between these two hormones in the natural history of breast cancer.",
keywords = "Breast cancer, Crosstalk, Estrogen receptor, Prolactin",
author = "Yen-Hao Chen and Kuangtzu Huang and Chen, {Kuanhui E.} and Walker, {Ameae M.}",
year = "2010",
month = "4",
day = "1",
doi = "10.1007/s10549-009-0400-7",
language = "English (US)",
volume = "120",
pages = "369--377",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Prolactin and estradiol utilize distinct mechanisms to increase serine-118 phosphorylation and decrease levels of estrogen receptor a in T47D breast cancer cells

AU - Chen, Yen-Hao

AU - Huang, Kuangtzu

AU - Chen, Kuanhui E.

AU - Walker, Ameae M.

PY - 2010/4/1

Y1 - 2010/4/1

N2 - Potential interactions between prolactin (PRL) and estradiol (E2) in breast cancer cells were explored by examining the effect of PRL on estrogen receptor (ER) serine-118 phosphorylation, ER down-regulation, and E2-stimulated cell proliferation. Both E2 and PRL resulted in prolonged ERα serine-118 phosphorylation, but used different signaling pathways to achieve this end. Both hormones also decreased the amount of ERα, but the mechanisms were different: for E2, the decrease was rapid and resulted from proteasomic degradation, whereas for PRL the decrease was slow and resulted from an effect on levels of ERα mRNA. PRL alone had no effect on cell number, but enhanced the increase in number in response to E2. These results are the first to demonstrate similar effects of PRL and E2 on parameters considered key to E2's effects. This suggests heretofore unrecognized and potentially important interactions between these two hormones in the natural history of breast cancer.

AB - Potential interactions between prolactin (PRL) and estradiol (E2) in breast cancer cells were explored by examining the effect of PRL on estrogen receptor (ER) serine-118 phosphorylation, ER down-regulation, and E2-stimulated cell proliferation. Both E2 and PRL resulted in prolonged ERα serine-118 phosphorylation, but used different signaling pathways to achieve this end. Both hormones also decreased the amount of ERα, but the mechanisms were different: for E2, the decrease was rapid and resulted from proteasomic degradation, whereas for PRL the decrease was slow and resulted from an effect on levels of ERα mRNA. PRL alone had no effect on cell number, but enhanced the increase in number in response to E2. These results are the first to demonstrate similar effects of PRL and E2 on parameters considered key to E2's effects. This suggests heretofore unrecognized and potentially important interactions between these two hormones in the natural history of breast cancer.

KW - Breast cancer

KW - Crosstalk

KW - Estrogen receptor

KW - Prolactin

UR - http://www.scopus.com/inward/record.url?scp=77950689679&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950689679&partnerID=8YFLogxK

U2 - 10.1007/s10549-009-0400-7

DO - 10.1007/s10549-009-0400-7

M3 - Article

VL - 120

SP - 369

EP - 377

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 2

ER -